These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20302552)

  • 41. The Year in Cardiology 2012: focus on cardiovascular disease prevention.
    Charakida M; Masi S; Deanfield JE
    Eur Heart J; 2013 Jan; 34(4):314-7. PubMed ID: 23284098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
    Fuchs FD; DiNicolantonio JJ
    Open Heart; 2015; 2(1):e000236. PubMed ID: 25893104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm.
    Garcia-Moll X; Barrios V; Franch-Nadal J
    Drugs Context; 2021; 10():. PubMed ID: 34466139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure.
    Singh V
    Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699
    [No Abstract]   [Full Text] [Related]  

  • 45. Review: rosiglitazone increases risk of MI but does not differ from other drugs for CV death in type 2 diabetes.
    Hlatky MA; Bravata DM
    Evid Based Med; 2007 Dec; 12(6):169-70. PubMed ID: 18063729
    [No Abstract]   [Full Text] [Related]  

  • 46. Radionuclide imaging of neurohormonal system of the heart.
    Chen X; Werner RA; Javadi MS; Maya Y; Decker M; Lapa C; Herrmann K; Higuchi T
    Theranostics; 2015; 5(6):545-58. PubMed ID: 25825596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.
    Wright JW; Kawas LH; Harding JW
    Front Endocrinol (Lausanne); 2013 Oct; 4():158. PubMed ID: 24298267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.
    Fukushima K; Bravo PE; Higuchi T; Schuleri KH; Lin X; Abraham MR; Xia J; Mathews WB; Dannals RF; Lardo AC; Szabo Z; Bengel FM
    J Am Coll Cardiol; 2012 Dec; 60(24):2527-34. PubMed ID: 23158533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.
    Wright JW; Harding JW
    Pflugers Arch; 2013 Jan; 465(1):133-51. PubMed ID: 22535332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for the efficacy of ARBs across the cardiovascular continuum.
    Gupta M; Honos GN; Velazquez EJ; Chung N; Oigman W; Maggioni AP
    Curr Med Res Opin; 2010 May; 26(5):1203-18. PubMed ID: 20302552
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
    Epstein BJ; Gums JG
    Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.